Sector: Finance - Financial Services
BSE Code: 512217
NSE Symbol: PRISMMEDI
ISIN: INE730E01016
📊 Prism Medico Reports Zero Investor Complaints for Q4 FY26 • Zero investor complaints reported for quarter ended March 31, 2026 • No complaints pending at start, received during, or unresolved at end of quarter • Compliance report submitted under SEBI Listing Obligations • Registrar and Transfer…
📊 Prism Medico and Pharmacy Ltd: No Promoter Shares Encumbered in FY26 - No shares held by promoters or persons acting in concert were encumbered during FY26. - Confirmation was provided by one promoter on behalf of all promoters and persons acting in concert. - Company ISIN: INE730E01016 - Stock…
📢 Prism Medico & Pharmacy Ltd: No Non-Convertible Securities Issued - Prism Medico and Pharmacy Limited has not issued any non-convertible securities. - No interest, dividend, or principal payments were due for the period from January 1, 2026, to March 31, 2026.
📋 Prism Medico and Pharmacy Ltd: No Non-Convertible Securities Issued • Prism Medico and Pharmacy Limited has not issued any non-convertible securities • No interest, dividend, or principal payments are due for the quarter from April 1, 2026 to June 30, 2026 • This disclosure is made under SEBI L…
📈 Prism Medico and Pharmacy Ltd Responds to Stock Movement Inquiry - Company states all material information has been disclosed as required - Price movement attributed to market conditions and speculation, not company-specific factors - Confirms no recent trading by promoters or Key Managerial Pe…
Prism Medico and Pharmacy Ltd. Shareholders Overwhelmingly Approve Key Resolutions 📋 - Extraordinary General Meeting held on March 20, 2026 via video conferencing/audio visual means - Two special resolutions passed: Altering Clause 15 of Articles of Association and issuing equity shares/convertib…
📊 Prism Medico & Pharmacy Ltd. EGM Recap: Key Decisions & Voting Details - Held Extraordinary General Meeting (EGM) on March 20, 2026, from 1:00 PM to 1:17 PM via video conferencing. - Chaired by Mrs. Sakshi Laller, Whole-time Director. - Total of 4,366 shareholders as of record date March 13, 20…
📊 Prism Medico Shareholders Approve Key Changes in EGM - Extraordinary General Meeting held March 20, 2026 at 1:00 PM via video conferencing - Meeting concluded at 1:17 PM (17 minutes duration) - Approved alteration of Clause 15 of Articles of Association - Approved issuance of equity shares and …
🏦 Key Financial Updates: Loan Recoveries & Fund Allocation - Utkarsh Small Finance Bank Limited has taken possession of properties due to loan defaults, with outstanding amounts ranging from INR 4.89 lakh to INR 28.42 lakh. - Prism Medico and Pharmacy Limited issued a corrigendum for its Extraord…
📅 Prism Medico and Pharmacy Ltd Announces Key Dates for Shareholder Meeting - Extra Ordinary General Meeting scheduled for March 20, 2026 at 01:00 PM via Video Conferencing or Audio Visual Means - Book closure period from March 14, 2026 to March 20, 2026 inclusive - Remote e-voting available from…
Prism Medico Plans ₹25 Cr Capital Raise via Preferential Issue 📈 • Board approved issuance of up to 7,500,000 equity shares at ₹20 per share (₹15 crore total) • Approved issuance of up to 5,000,000 convertible warrants at ₹20 per warrant (₹10 crore total) • Allotment targets include Symbiosis Pha…
📋 Prism Medico and Pharmacy Ltd Announces Key Board Meeting & Fundraising Plans - Board meeting scheduled for February 23, 2026, at 1:00 PM at the registered office in Kala Amb, Himachal Pradesh. - Agenda includes considering alteration of the Articles of Association, subject to shareholder appro…
📊 Prism Medico Q3 FY26 Results: Net Loss Narrows to ₹1.34 Lakh • Net loss of ₹1.34 lakh for Q3 FY26 (Dec 31, 2025) • Previous quarter net loss was ₹8.48 lakh (Sept 30, 2025) • Total expenses: ₹9.13 lakh • Cost of materials consumed: ₹4.25 lakh • Other expenses: ₹3.6 lakh • Other income: ₹0.69 lak…
📅 Prism Medico and Pharmacy Ltd Board Meeting Set for February 13, 2026 - Board meeting scheduled for February 13, 2026, at 1:00 PM - Venue: Registered office in Kala Amb, Himachal Pradesh - Agenda includes approval of unaudited standalone financial results for quarter ended December 31, 2025 - R…
🌐 Prism Medico and Pharmacy Ltd Website Now Live as per SEBI Requirements • Prism Medico and Pharmacy Limited confirms its website is now functional as required by SEBI Regulation 46 • The company's website address is https://www.prismmedico.in
Prism Medico & Pharmacy Reports Zero Investor Complaints in Q3 2025 📊 - Zero investor complaints for the quarter ended December 31, 2025. - No complaints pending at the start, received during, or resolved in the quarter. - Scrip code: 512217 | ISIN: INE730E01016. - Report submitted to BSE Limited…
🔍 Prism Medico & Pharmacy Ltd: Key Financial Update for Q3 2025 - Prism Medico and Pharmacy Limited (ISIN: INE730E01016) provided a regulatory update for Q3 2025 (Oct 1 - Dec 31). - The company confirmed it has not issued any non-convertible securities. - No interest, dividend, or principal payme…
Prism Medico & Pharmacy Ltd: No Non-Convertible Securities Issued in Q1 2026 📊 - Prism Medico and Pharmacy Ltd did not issue any non-convertible securities from January 1, 2026, to March 31, 2026. - No interest, dividend, or principal payments were due during this quarter. - The company's registe…
📊 Prism Medico Q2 FY2025 Results: Revenue at ₹50.23L, Net Loss of ₹8.48L - Revenue from Operations: ₹50.23 lakhs (quarter), ₹292.52 lakhs (year ended March 2024) - Net Loss: ₹(8.48) lakhs (quarter), ₹(2.13) lakhs (year ended March 2024) - Total Assets: ₹1,583.36 lakhs (as of 30th September 2025) …
Prism Medico & Pharmacy Q2 FY2025 Results: Revenue at ₹50.23 Lakhs 📊 - Board approved Unaudited Standalone Financial Results for Q2 & H1 ended 30th Sept 2025 - Revenue from operations: ₹50.23 lakhs (quarter) - Total income from operations: ₹51.90 lakhs (quarter) - Total expenses: ₹60.38 lakhs (qu…